Insights

Expanding Specialty Portfolio Advanz Pharma's focus on specialty, hospital, and rare disease medicines, including innovative products like the recent launch of generic lanreotide, presents numerous opportunities to supply hospitals, specialty clinics, and niche healthcare providers across Europe, Canada, and Australia.

Strong Partnership Network The company's strategic collaborations with biotech firms, distributors, and partners such as Altamira Therapeutics and Biosimilar Development create multiple channels for introducing new therapeutic areas and expanding market penetration in niche segments.

Global Market Presence With commercial sales in more than 90 countries and direct presence in key markets including the US, Europe, Canada, and Australia, Advanz Pharma offers sales teams access to diverse, high-potential regions for targeted outreach and product distribution.

Innovative Pipeline Leadership Advanz Pharma’s pipeline of biosimilars, specialty generics, and originator brands across therapeutic areas such as hepatology, gastroenterology, and CNS indicates opportunities to introduce new or existing medicines tailored to unmet needs within hospital networks and specialty clinics.

Digital and Regulatory Readiness Utilizing advanced tech stacks like SAP ERP, GDPR compliance, and digital platforms enables efficient sales and marketing operations, making it easier to identify, target, and engage decision-makers within healthcare institutions across diverse regions.

ADVANZ PHARMA Tech Stack

ADVANZ PHARMA uses 8 technology products and services including SAP FICO, GDPR, Cybot, and more. Explore ADVANZ PHARMA's tech stack below.

  • SAP FICO
    Accounting
  • GDPR
    Certificates
  • Cybot
    Cookie Compliance
  • Cookiebot
    Cookie Compliance
  • Anaplan
    Corporate Performance Management
  • Mailchimp
    Email
  • SAP ERP
    Enterprise Resource Planning
  • GoDaddy
    Web Hosting

Media & News

ADVANZ PHARMA's Email Address Formats

ADVANZ PHARMA uses at least 1 format(s):
ADVANZ PHARMA Email FormatsExamplePercentage
First.Last@advanzpharma.comJohn.Doe@advanzpharma.com
97%
First.Middle@advanzpharma.comJohn.Michael@advanzpharma.com
2%
Middle@advanzpharma.comMichael@advanzpharma.com
1%

Frequently Asked Questions

What is ADVANZ PHARMA's official website and social media links?

Minus sign iconPlus sign icon
ADVANZ PHARMA's official website is advanzpharma.com and has social profiles on LinkedInCrunchbase.

What is ADVANZ PHARMA's NAICS code?

Minus sign iconPlus sign icon
ADVANZ PHARMA's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ADVANZ PHARMA have currently?

Minus sign iconPlus sign icon
As of December 2025, ADVANZ PHARMA has approximately 707 employees across 5 continents, including EuropeAsiaNorth America. Key team members include Ceo: S. W.Chief Financial Officer: A. S.Chief Commercial Officer: S. T.. Explore ADVANZ PHARMA's employee directory with LeadIQ.

What industry does ADVANZ PHARMA belong to?

Minus sign iconPlus sign icon
ADVANZ PHARMA operates in the Pharmaceutical Manufacturing industry.

What technology does ADVANZ PHARMA use?

Minus sign iconPlus sign icon
ADVANZ PHARMA's tech stack includes SAP FICOGDPRCybotCookiebotAnaplanMailchimpSAP ERPGoDaddy.

What is ADVANZ PHARMA's email format?

Minus sign iconPlus sign icon
ADVANZ PHARMA's email format typically follows the pattern of First.Last@advanzpharma.com. Find more ADVANZ PHARMA email formats with LeadIQ.

How much funding has ADVANZ PHARMA raised to date?

Minus sign iconPlus sign icon
As of December 2025, ADVANZ PHARMA has raised $1.2B in funding. The last funding round occurred on Apr 10, 2025 for $1.2B.

ADVANZ PHARMA

Pharmaceutical ManufacturingEngland, United Kingdom501-1000 Employees

Partner of choice in specialty, hospital, and rare disease medicines

ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on.

Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients.

Headquartered in London, UK, we have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia. Our Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network complement our global operations.

ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, specialty generics & biosimilars, and originator brands. Our products and pipeline cover a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases.

We can only achieve our ambition with the passion of our dedicated and highly qualified people, acting in line with our company values of entrepreneurship, speed, and integrity.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $1.2B

    ADVANZ PHARMA has raised a total of $1.2B of funding over 4 rounds. Their latest funding round was raised on Apr 10, 2025 in the amount of $1.2B.

  • $50M$100M

    ADVANZ PHARMA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $1.2B

    ADVANZ PHARMA has raised a total of $1.2B of funding over 4 rounds. Their latest funding round was raised on Apr 10, 2025 in the amount of $1.2B.

  • $50M$100M

    ADVANZ PHARMA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.